Le Lézard
Classified in: Health
Subjects: VET, TRI, FVT, DEI

New Research Shows that Wounds heal faster with Gladiator Therapeutics Patented SemiCeraŽ Technology


WHITEHALL, Pa., Aug. 30, 2021 /PRNewswire/ -- Gladiator Therapeutics, LLC is excited to announce that independent researchers at the University of Central Florida College of Medicine have finalized the results of their wound healing research. The researchers used Gladiator's non-powered SemiCeraŽ technology in a study that increased wound healing. The study abstract was accepted for presentation at the Military Health System Research Symposium (MHSRS), scheduled in Kissimmee, Florida, Aug 23-26, 2021. The MHSRS is the USA Department of Defense's premier scientific meeting that focuses specifically on the unique medical needs of the Warfighter.

The Gladiator ceramic blanket can be used anywhere without the need for a power supply and without the side effects.

The scientists found that wounds healed significantly faster when wounded animals and stem cells were exposed to the Gladiator Technology. The abstract of the UCF COM research is published on the MHSRS website as a public service by the United States Army Medical Research and Development Command, MHSRS-21-02823 Regenerative properties and wound healing of a novel far-infrared ceramic blanket. The Gladiator ceramic blanket can be used anywhere without the need for a power supply and without the side effects that are commonly found when injecting chemicals or drugs. The UCF research team is conducting ongoing research on the use of the Gladiator ceramic blanket in animal models of Alzheimer's disease, Parkinson's disease, and traumatic brain injury.

For more information, visit www.gladiatortherapeutics.com.

About Gladiator Therapeutics

Gladiator Therapeutics is an FDA-registered medical device research and manufacturing company utilizing patented non-powered specific far infrared technology. Their corporate office is in Emmaus, PA. The focus that drives the company is to complete and certify their unique technology for a variety of clinical applications to improve the quality of life for those with difficult to treat conditions, such as chronic wounds.

Contact:
Kim Nahf
[email protected]

SOURCE Gladiator Therapeutics


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: